Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 26, 2024

BUY
$3.56 - $6.04 $54,233 - $92,013
15,234 New
15,234 $78,000
Q2 2023

Jul 27, 2023

BUY
$4.42 - $8.55 $81,540 - $157,730
18,448 New
18,448 $108,000
Q3 2022

Nov 07, 2022

BUY
$0.14 - $2.66 $6,456 - $122,676
46,119 New
46,119 $73,000

Others Institutions Holding RVPH

About REVIVA PHARMACEUTICALS HOLDINGS, INC.


  • Ticker RVPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,442,900
  • Market Cap $23.1M
  • Description
  • Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...
More about RVPH
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.